Observation for the clinical effect of compound Qihuo tablet in the treatment of elderly osteoporotic low back pain

onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•1. Meet the diagnostic criteria of western medicine for primary osteoporosis (T value <=-2.5SD is osteoporosis), meanwhile, TCM syndromes are patients with kidney deficiency and blood stasis syndrome;
•2. Males and female patients aged 60 to 80 years old;
•3. Those who have signed an informed consent form, are willing to accept examinations, treatments and can cooperate with follow-up;
•4. Those who have not received any other treatment plan.

•1. People with allergies;
•2. Patients with secondary osteoporosis such as hyperparathyroidism, osteomalacia, rheumatoid arthritis, gout, multiple myeloma and other secondary osteoporosis; Patients with various endocrine diseases (such as Cushings disease, hyperthyroidism, hyperparathyroidism, hypothyroidism, diabetes, etc.);
•3. With severe heart disease, severe liver and kidney insufficiency, malignant hypertension, severe heart failure, Severe arrhythmia;
•4. Other serious diseases that affect bone metabolism; people who have been taking other drugs that affect bone metabolism at the same time for a long time and cannot be stopped immediately;
•5. patients with mental illness;
•6. those who have or are currently suffering from fractures other than the lumbar spine; Or those with hip implants;
•7. Late deformity, disability, loss of labor;
•8. People with a history of opioid analgesics, sedative hypnotics and alcohol abuse;
•9. People with poor compliance and unable to meet follow-up requirements;
•10. Pregnant and lactating women;
•11. Patients with high blood calcium, or patients with kidney stone.

发起方

onghua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine